A comparison of DNA testing for Familial Hypercholesterolaemia (FH) with traditional diagnostic methods and the implications for cascade testing.

To compare the number of affected relatives found by cascade testing from index patients where

(a) a specific DNA mutation has been found, and
(b) no mutation has been found.

To use this information to compare the cost effectiveness of DNA testing and cholesterol testing in FH identification.